Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06050148
PHASE2/PHASE3
Faecal Microbiota Transplantation as Means of Preventing Recurrent Urinary Tract Infections
Sponsor: Helsinki University Central Hospital
View on ClinicalTrials.gov
Summary
This study investigates Faecal microbiota transplantation (FMT) in prevention of recurrent urinary tract infections (UTIs) caused either by sensitive E. coli or ESBL-E. coli.
Key Details
Gender
FEMALE
Age Range
18 Years - 90 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2023-08-01
Completion Date
2029-12-31
Last Updated
2023-09-22
Healthy Volunteers
Yes
Conditions
Interventions
BIOLOGICAL
Feacal microbial transplantation (FMT)
Feacal microbial transplantation (FMT)
OTHER
Placebo transplantation (PT)
Transplantation with coloured 0,9% NaCl-solution
Locations (1)
Meilahti Vaccine Research Center, Helsinki University Central Hospital
Helsinki, Finland